Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment

Australian Psychologist

Volumn 40, Issue 2, 2005, Pages 88-95

  Baker, A ^a   Dawe, S ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23744487971     PISSN: 00050067     EISSN: 17429544     Source Type: Journal    
DOI: 10.1080/00050060500094654     Document Type: Review

References (68)

1. Abraham, H. D., & Fava, M. (1999). Order of onset of substance abuse and depression in a sample of depressed outpatients. Comprehensive Psychiatry, 40, 44-50.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of psychiatric disorders (4th ed.). Washington DC: American Psychiatric Association.
3. Back, S. E., Dansky, B. S., Carroll, K. M., Foa, E. B., & Brady, K. T. (2001). Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: Description of procedures. Journal of Substance Abuse Treatment, 21, 35-45.
4. Baillie, A. J., & Rapee, R. M. (2003). Predicting who benefits from psychoeducation and self-help for panic attacks. Behavior Research and Therapy, 42, 513-527.
5. Baker, A., Boggs, T., & Lewin, T. (2001 a). Characteristics of regular amphetamine users and implications for treatment. Drug and Alcohol Review, 20, 49-56.
6. Baker, A., Boggs, T., & Lewin, T. (2001b). Randomized controlled trial of brief cognitive-behavioural interventions among regular users of amphetamine. Addiction, 96, 12791287.
7. Baker, A., Gowing, L., Lee, N. K., & Proudfoot, H. (2004). Psychosocial interventions. In A. Baker, N. K. Lee, & L. Jenner (Eds.), Models of intervention and care for psychostimulant users (2nd ed.) National Drug Strategy Monography Series No. 51 (pp. 63-84). Canberra: Australian Government Department of Health and Ageing.
8. Baker, A., & Lee, N. (2003). A review of psychostimulant interventions for amphetamine use. Drug and Alcohol Review, 22, 323-336.
9. Baker, A., Lee, N. K., Claire, M., Lewin, T. J., Grant, T., Pohlman, S., et al. (2004). Drug use patterns and mental health of regular amphetamine users during a reported 'heroin drought'. Addiction, 99, 875-884.
10. Baker, A., Lee, N. K., Claire, M., Lewin, T. J., Grant, T., Pohlman, S., et al. (2005). Brief cognitive-behavioural interventions among regular amphetamine users: a step in the right direction. Addiction, 100, 367-378.
11. Baker, A., Lewin, T., Reichler, H., Clancy, R., Carr, V., Garrett, R., et al. (2002). Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatrica Scandinavica, 106, 233-240.
12. Bakken, K., Landheim, A. S., & Vaglum, P. (2003). Primary and secondary substance misusers: Do they differ in substance-induced and substance independent mental disorders? Alcohol & Alcoholism, 38, 54-59.
13. Bowman, J. A., & Walsh, R. A. (2003). Smoking intervention within alcohol and other drug treatment services: A selective review with suggestions for practical management. Drug and Alcohol Review, 22, 73-82.
14. Breslin, F. C., Sobell, M. B., Sobell, L.C., Buchan, G., & Cunningham, J. A. (1997). Toward a stepped care approach to treating problem drinkers: The predictive utility of within-treatment variables and therapist prognostic ratings. Addiction, 92, 1479-1489.
15. Burling, T. A., & Ziff, D. C. (1988). Tobacco smoking: A comparison between alcohol and drug abuse inpatients. Addictive Behaviours, 13, 185-190.
16. Burns, L., & Teesson, M. (2002). Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental health and Well Being. Drug and Alcohol Dependence, 68, 299-307.
17. Cantwell, B., & McBride, A. J. (1998). Self detoxification by amphetamine dependent patients: A pilot study. Drug and Alcohol Dependence, 49, 157-163.
18. Carroll, K. M. (1997). Integrating psychotherapy and pharma-cotherapy to improve drug abuse outcomes. Addictive Behaviors, 22, 233-245.
19. Castro, F. G., Barrington, E. H., Walton, M. A., & Rawson, R. A. (2000). Cocaine and methamphetamine: Differential addiction rates. Psychology of Addictive Behaviors, 14, 390-396.
20. Darke, S., & Hall, W. (1995). Levels and correlates of polydrug use among heroin users. Drug and Alcohol Dependence, 93, 231-235.
21. Darke, S., Ross, J., & Cohen, J. (1994). The use of benzodiazepines among regular amphetamine users. Addiction, 89, 1683-1690.
22. Dawe, S., & McKetin, R. (2004). The psychiatric comorbidity of psychostimulant use. In A. Baker, N. K. Lee, & L. Jenner (Eds.), Towards better interventions and care for psychostimulant users (2nd ed.,. pp. 154-168). Canberra: Commonwealth of Australia.
23. Dawe, S., Saunders, J., Kavanagh, D., & Young, R. (submitted). The relationship between drug use, mood and psychotic symptoms in a sample of injecting methamphetamine users.
24. Dean, A. (2004). Pharmacology of psychostimulants. In: A. Baker, N. K. Lee, & L. Jenner (Eds.), Towards better interventions and care for psychostimulant users (2nd ed., pp. 35-50). Canberra: Commonwealth of Australia.
25. Edwards, J., & McGorry, P. (Eds.) (2002). Implementing early intervention in psychosis: A guide to establishing early psychosis services. London: Martin Dunitz.
26. Fowler, I. L., Carr, V. J., Carter, N. T., & Lewin, T. J. (1998). Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin, 24, 443-455.
27. Furr, C. D., Delva, J., & Anthony, J. C. (2000). The suspected association between methamphetamine ('ice') smoking and frequent episodes of alcohol intoxication: Data from the 1993 National Household Survey on Drug Abuse. Drug and Alcohol Dependence, 59, 89-93.
28. Glantz, M. D., & Leshner, A. I. (2000). Drug abuse and developmental psychopathology. Development and Psychopathology, 12, 795-814.
29. Goldenberg, I. M., Mueller, T., Fierman, E. J., Gordon, A., Pratt, L., Cox, K., et al. (1995). Specificity of substance use in anxiety-disordered subjects. Comprehensive Psychiatry, 36, 319-328.
30. Goodwin, R. D., Stayner, D. A., Chinman, M. J., Wu, P., Kraemer Tebes, J., & Davidson, L. (2002). The relationship between anxiety and substance use disorders among individuals with severe affective disorders. Comprehensive Psychiatry, 43, 245-252
31. Hall, W., Darke, S., Ross, M., & Wodak, A. (1993). Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia. Addiction, 88, 509-516.
32. Hall, W., & Hando, J. (1994). Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug and Alcohol Review, 13, 277-284.
33. Hall, W., Hando, J., Darke, S., & Ross, J. (1996). Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction, 91, 81-87.
34. Hall, W., Tesson, M., Lynskey, M., & Degenhardt, L. (1998). The prevalence in the past year of substance use and ICD-10 substance use disorders in Australian adults: Findings from the National Survey of Mental Health and Well-Being (NDARC Technical Report No.63). Sydney: NDARC.
35. Heather, N., & Tebbutt, J. (Eds.) (1989). The effectiveness of treatment for drug and alcohol problems: An overview (Monograph Series No. 11). Canberra: Australian Government Publishing Service.
36. Hides, L., Dawe, S., Kavanagh, D., & Young, R. (submitted). The influence of cannabis on symptom exacerbation and relapse in early psychosis.
37. Iwanami, A., Sugiyama, A., Kuroki, N., Toda, S., Kato, N., Nakatani, Y., et al. (1994). Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatrica Scandinavica, 89, 428-432.
38. Jenner, L., & McKetin, R. (2004). Prevalence and patterns of psychostimulants. In: A. Baker, N. Lee & L. Jenner (Eds), Models of intervention and care for psychostimulant users (2nd Ed) National Drug Strategy Monograph Series No. 51 (pp. 63-84). Canberra: Commonwealth of Australia.
39. Kalechstein, A. D., Newton, T. F., Longshore, D., van Gorp, W. G., & Gawin, F. H. (2000). Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 480-484.
40. Kavanagh, D. J., Mueser, K. T., & Baker, A. (2003). Management of comorbidity. In M. Teesson & H. Proudfoot (Eds.), Comorbid mental disorders and substance use disorders: Epidemiology, prevention and treatment (pp. 78-120). Canberra: Commonwealth of Australia.
41. King, V. L., Stoller, K. B., Hayes, M., Umbricht, A., Currens, M., Kidorf, M. S., et al. (2002). A multicentre randomised evaluation of methadone medical maintenance. Drug and Alcohol Dependence, 65, 137-148.
42. Kurst-Swanger, K., & Stockweather, D. (2003). Maintaining addiction: Tobacco cessation policy and substance abuse treatment for youth. Journal of Child and Adolescent Substance Abuse, 12, 71-86
43. Maxwell, J. C. (2003). Update: Comparison of drug use in Australia and the United States as seen in the 2001 National Household Surveys. Drug and Alcohol Review, 22, 347-357.
44. Mueser, K. T., Yarnold, P. R., & Bellack, A. S. (1992). Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatrica Scandinavica, 85, 48-55.
45. Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis: A review of etiological theories. Addictive Behaviors, 23, 717-734.
46. Newman, M. G. (2000). Recommendations for a cost-offset model of psychotherapy allocation using generalized anxiety disorder as an example. Journal of Consulting and Clinical Psychology, 68, 549-555.
47. Otto, M. W., Pollack, M. H., & Maki, K. M. (2000). Empirically supported treatments for panic disorder: Costs, benefits, and stepped care. Journal of Consulting and Clinical Psychology, 68, 556-563.
48. Rawson, R., Huber, A., Bremen, P., Obert, J., Gulati, V., Shoptaw, S., et al. (2000). Methamphetamine and cocaine users: Differences in characteristics and treatment retention. Journal of Psychoactive Drugs, 32, 233-238.
49. Rawson, R. A., Huber, A., Brethen, P., Obert, J., Gulati, V., Shoptaw, S., et al. (2002). Status of methamphetamine users 2-5 years after outpatient treatment. Journal of Addictive Diseases, 21, 107-119.
50. Riehman, K. S., Iguchi, M. Y., & Anglin, M. D. (2002). Depressive symptoms among amphetamine and cocaine users before and after substance abuse treatment. Psychology of Addictive Behaviors, 16, 333-337.
51. Rounsaville, B. J., Petry, N. M., & Carroll, K. M. (2003). Single versus multiple drug focus in substance abuse clinical trials research. Drug and Alcohol Dependence, 70, 117-125.
52. Sato, M., Numachi, Y., & Hamamura, T. (1992). Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophrenia Bulletin 18, 115-122.
53. Schippers, G. M., Schramade, M., & Walburg, J. A. (2002). Reforming Dutch substance abuse treatment services. Addictive Behaviour, 27, 995-1007.
54. Scogin, F. R., Hanson, A., & Welsh, D. (2003). Self-administered treatment in stepped-care models of depression treatment. Journal of Clinical Psychology, 59, 341-349.
55. Segal, D. S., & Kuczenski, R. (1997). Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration. Behavioural Brain Research, 88, 251-260.
56. Segal, D. S., & Kuczenski, R. (1999). Escalating dose-binge stimulant exposure: Relationship between emergent behavioral profile and differential caudate-putamen and nucleus accumbens dopamine responses. Psychopharmacology, 142, 182-192.
57. Shaner, A., Roberts, L. J., Eckman, T. A., Racenstein, J. M., Tucker, D. E., Tsuang, J. W., et al. (1998). Sources of diagnostic uncertainty for chronically psychotic cocaine abusers. Psychiatric Services, 49, 684-690.
58. Sobell, M. B., & Sobell, L. C. (2000). Stepped care as a heuristic approach to the treatment of alcohol problems. Journal of Consulting and Clinical Psychology, 68, 573-579.
59. Smith, S. S., Jorenby, D. E., Piasecki, T. M., Baker, T. B., Fiore, M. C., Anderson, J. E., et al. (2001). Strike while the iron is hot: Can stepped-care treatments resurrect relapsing smokers? Journal of Consulting and Clinical Psychology, 69, 429-439.
60. Srisurapanont, M., Jarusuraisin, N., & Jittawutikan, J. (1999). Amphetamine withdrawal I: Reliability, validity and factor structure of a measure. Australian and New Zealand Journal of Psychiatry, 33, 89-93.
61. Srisurapanont, M., Jarusuraisin, N., & Kittirattanapaiboon, P. (2002). Treatment for amphetamine dependence and abuse (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: Update Software.
62. Stitzer, M. L., & Walsh, S. L. (1997). Psychostimulant abuse: The case for combined behavioral and pharmacological treatments. Pharmacology, Biochemistry and Behaviour, 57, 457-470.
63. Topp, L., Day, C., & Degenhardt, L. (2003). Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug and Alcohol Dependence, 70, 275-286.
64. Ujike, H. (2002). Stimulant-induced psychosis and schizophrenia: The role of sensitization. Current Psychiatry Reports, 4, 177-184.
65. Vincent, N., Shoobridge, J., Ask, A., Allsop, S., & Ali, R. (1998). Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. Drug and Alcohol Review, 17, 187-195.
66. Williamson, S., Gossop, M., Powis, B., Griffiths, P., Fountain, J., & Strang, J. (1997). Adverse effects of stimulant drugs in a community sample of drug users. Drug and Alcohol Dependence, 44, 87-94.
67. Wilson, G. T., Vitousek, K. M., & Loeb, K. L. (2000). Stepped care treatment for eating disorders. Journal of Consulting and Clinical Psychology, 68, 564-572.
68. Yui, K., Ikemoto, S., Ishiguro, T., & Goto, K. (2000). Studies of amphetamine or methamphetamine psychosis in Japan: Relation of methamphetamine psychosis to schizophrenia. In S. F. Ali (Ed.), Neurobiological mechanisms of drugs of abuse: Cocaine, ibogaine, and substituted amphetamines (Vol. 914, pp. 1-12). New York: The New York Academy of Sciences.